INDOMETHACIN REDUCES THE ANTIHYPERTENSIVE ACTION OF ENALAPRIL

被引:33
作者
SALVETTI, A
ABDELHAQ, B
MAGAGNA, A
PEDRINELLI, R
机构
关键词
D O I
10.3109/10641968709164224
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:559 / 567
页数:9
相关论文
共 14 条
[1]   ROLE OF PROSTAGLANDIN IN THE ANTIHYPERTENSIVE MECHANISM OF CAPTOPRIL IN LOW RENIN HYPERTENSION [J].
ABE, K ;
ITO, T ;
SATO, M ;
HARUYAMA, T ;
SATO, K ;
OMATA, K ;
HIWATARI, M ;
SAKURAI, Y ;
IMAI, Y ;
YOSHINAGA, K .
CLINICAL SCIENCE, 1980, 59 :S141-S144
[2]   AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF ENALAPRIL [J].
DAVIES, RO ;
GOMEZ, HJ ;
IRVIN, JD ;
WALKER, JF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S215-S229
[3]  
GOLUB M, 1984, 10TH SCI M INT SOC H
[4]   EFFECTS OF INDOMETHACIN ALONE AND DURING DIURETIC OR BETA-ADRENORECEPTOR-BLOCKADE THERAPY ON BLOOD-PRESSURE AND THE RENIN SYSTEM IN ESSENTIAL HYPERTENSION [J].
LOPEZOVEJERO, JA ;
WEBER, MA ;
DRAYER, JIM ;
SEALEY, JE ;
LARAGH, JH .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 :S203-S205
[5]   PROSTACYCLIN MEDIATES THE POTENTIATED HYPOTENSIVE EFFECT OF BRADYKININ FOLLOWING CAPTOPRIL TREATMENT [J].
MULLANE, KM ;
MONCADA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 66 (04) :355-365
[6]  
OPARIL S, 1983, CLIN RES, V31, pA538
[7]   DIFFERENTIAL-EFFECTS OF SELECTIVE AND NON-SELECTIVE PROSTAGLANDIN-SYNTHESIS INHIBITION ON THE PHARMACOLOGICAL RESPONSES TO CAPTOPRIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
SALVETTI, A ;
PEDRINELLI, R ;
MAGAGNA, A ;
UGENTI, P .
CLINICAL SCIENCE, 1982, 63 :S261-S263
[8]   THE INFLUENCE OF INDOMETHACIN AND SULINDAC ON SOME PHARMACOLOGICAL ACTIONS OF ATENOLOL IN HYPERTENSIVE PATIENTS [J].
SALVETTI, A ;
PEDRINELLI, R ;
ALBERICI, P ;
MAGAGNA, A ;
ABDELHAQ, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 :S108-S111
[9]   INTERACTION BETWEEN OXPRENOLOL AND INDOMETHACIN ON BLOOD-PRESSURE IN ESSENTIAL HYPERTENSIVE PATIENTS [J].
SALVETTI, A ;
ARZILLI, F ;
PEDRINELLI, R ;
BEGGI, P ;
MOTOLESE, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (03) :197-201
[10]  
SALVETTI A, 1980, DRUG EXP CLIN RES, V6, P541